Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

Clinical trial NCT01466036 · COMPLETED

Trial details

NCT number: NCT01466036
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoid Tumor Pancreatic Neuroendocrine Tumor

Start date: 2012-07-01
Primary completion: 2021-08-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.